FDA and USP to Co-sponsor Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue

If your email program has trouble displaying this email, view as a webpage.

FDA and USP to Co-sponsor Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue

March 31, 2023

Dear International Colleague,

The U.S. Food and Drug Administration and United States Pharmacopeia (USP) are co-sponsoring the Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue. This program aims to accelerate APEC and global efforts to strengthen the resilience of global medical product supply chains.

This meeting will bring international medical product regulators, multilateral organization representatives, and industry and academic professionals together, to discuss public health priorities, the impact of the COVID-19 pandemic on supply chains, and why the APEC Supply Chain Security Toolkit continues to be a valuable tool to stakeholders.

Dates: April 25-26, 2023
Day 1: Tue, Apr. 25, 8:30 a.m.- 5:20 p.m. ET
Day 2: Wed, Apr. 26, 8:30 a.m.- 5:15 p.m. ET

Location:
Attend Online or
USP Rockville
12601 Twinbrook Parkway
Rockville, MD 20852
United States

This event is open to the public and free of cost.

Topics will include:

• APEC Roadmap to promote global medical product quality and supply chain security
• Identifying vulnerabilities in the upstream supply chain
• Mitigating and managing risks in raw material quality and supply chain security
• Manufacturing solutions to strengthen global supply chain resilience
• Experiences strengthening quality assurance in the Asia Pacific
• Safeguarding patients from impurities in the drug supply chain
• The supply chain imperative to fight AMR
• Securing the downstream supply chain - good distribution practices and postmarketing surveillance
• Securing the downstream supply chain - internet pharmacies

Confirmed FDA Speakers

Mark Abdoo

Associate Commissioner for Global Policy and Strategy 

Office of Global Policy and Strategy | Office of Policy, Legislation, and International Affairs | Office of the Commissioner | FDA

S. Leigh Verbois, Ph.D.

Director

Office of Drug Security, Integrity, and Response | Office of Compliance | Center for Drug Evaluation and Research (CDER) | FDA

Sangeeta Chatterjee, PharmD

Deputy Director

Office of Drug Security, Integrity, and Response | Office of Compliance | Center for Drug Evaluation and Research (CDER) | FDA

Contact

For questions, please email RFD@USP.org.

Additional Information

• Asia Pacific Economic Cooperation (APEC) Supply Chain Security Toolkit for Medical Products
• Asia-Pacific Economic Cooperation (apec.org)
• US Pharmacopeia (USP)
• USP-APEC Center of Excellence for Securing Medical Product Quality Through the Supply Chain
• FDA Office of Compliance, Office of Drug Security, Integrity, and Response
• FDA Office of Global Policy and Strategy